

Swizing Biosciences proudly presents CLAVZIN-625, a powerful and synergistic combination of Amoxicillin 500 mg and Potassium Clavulanate 125 mg. With a new look and the same trusted formulation, CLAVZIN-625 delivers broad-spectrum antibacterial action and consistent, reliable outcomes in the treatment of various bacterial infections.
What is CLAVZIN-625?
CLAVZIN-625 is a dual-action formulation made of:
Amoxicillin – A penicillin-class antibiotic that kills bacteria by inhibiting cell wall synthesis.
Potassium Clavulanate – A β-lactamase inhibitor that protects amoxicillin from enzymatic degradation caused by resistant bacteria.
Together, they create a potent solution capable of treating infections caused by both sensitive and resistant bacterial strains.
New Look, Same Trusted Power
The all-new packaging of CLAVZIN-625 reflects our focus on modernization, clarity, and trust. Designed with healthcare professionals and patients in mind, the new look offers:
Clear labeling for easier identification and dispensing
Enhanced protection for better product stability
Professional visual identity that aligns with global healthcare standards
This refreshed presentation is more than just cosmetic—it’s part of Swizing Biosciences’ continued dedication to excellence, reliability, and innovation in every detail.
Why Choose CLAVZIN-625 by Swizing Biosciences?
At Swizing Biosciences, we prioritize quality, efficacy, and patient outcomes. CLAVZIN-625 represents a reliable, clinically trusted antibiotic solution—trusted by physicians and pharmacists nationwide. The product’s updated appearance underscores our relentless pursuit of excellence in healthcare delivery.
Also read: Swizing by Rouzel Pharma – Advancing Excellence in Premium Healthcare Solutions.
👉 Explore the blog
